Correlation Between Century Therapeutics and DiaMedica Therapeutics
Can any of the company-specific risk be diversified away by investing in both Century Therapeutics and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Century Therapeutics and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Century Therapeutics and DiaMedica Therapeutics, you can compare the effects of market volatilities on Century Therapeutics and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Century Therapeutics with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Century Therapeutics and DiaMedica Therapeutics.
Diversification Opportunities for Century Therapeutics and DiaMedica Therapeutics
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Century and DiaMedica is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Century Therapeutics and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and Century Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Century Therapeutics are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of Century Therapeutics i.e., Century Therapeutics and DiaMedica Therapeutics go up and down completely randomly.
Pair Corralation between Century Therapeutics and DiaMedica Therapeutics
Given the investment horizon of 90 days Century Therapeutics is expected to under-perform the DiaMedica Therapeutics. In addition to that, Century Therapeutics is 1.98 times more volatile than DiaMedica Therapeutics. It trades about -0.18 of its total potential returns per unit of risk. DiaMedica Therapeutics is currently generating about -0.08 per unit of volatility. If you would invest 438.00 in DiaMedica Therapeutics on August 24, 2024 and sell it today you would lose (20.00) from holding DiaMedica Therapeutics or give up 4.57% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Century Therapeutics vs. DiaMedica Therapeutics
Performance |
Timeline |
Century Therapeutics |
DiaMedica Therapeutics |
Century Therapeutics and DiaMedica Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Century Therapeutics and DiaMedica Therapeutics
The main advantage of trading using opposite Century Therapeutics and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Century Therapeutics position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.Century Therapeutics vs. Lyra Therapeutics | Century Therapeutics vs. Hookipa Pharma | Century Therapeutics vs. Cingulate Warrants | Century Therapeutics vs. SAB Biotherapeutics |
DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
CEOs Directory Screen CEOs from public companies around the world | |
Money Managers Screen money managers from public funds and ETFs managed around the world |